Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Eszopiclone 3 mg Tablets Under Fed Conditions
NCT02322658Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Sep 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eszopiclone in Insomnia (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve at 48 hours. Started Sep 2008; status: completed.
02
Drugs
eszopiclone
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02322658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322658.